NCT03216408View on ClinicalTrials.gov

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines

PHASE3CompletedINTERVENTIONAL
Enrollment

504

Participants

Timeline

Start Date

March 30, 2016

Primary Completion Date

November 10, 2016

Study Completion Date

March 7, 2017

Conditions
Glabellar Lines
Interventions
DRUG

Neuronox

DRUG

Botox

All Listed Sponsors
lead

Medy-Tox

INDUSTRY

NCT03216408 - Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines | Biotech Hunter | Biotech Hunter